What Is DHM and Does It Actually Work? post-celebration

What Is DHM and Does It Actually Work?

Dihydromyricetin — the ingredient getting serious attention in wellness circles — explained.

If you've been exploring post-celebration wellness supplements, you've probably come across the acronym DHM. It shows up on ingredient labels, in supplement forums, and increasingly in conversations about how the body processes alcohol. But what is it, exactly? Where does it come from? And does the science actually hold up?

Here's a clear-eyed look at dihydromyricetin - what it is, how it works, and why delivery method matters more than most people realize.

What Is DHM (Dihydromyricetin)?

Dihydromyricetin - commonly abbreviated as DHM - is a naturally occurring flavonoid found in the Japanese raisin tree (Hovenia dulcis). The plant has been used in traditional East Asian medicine for centuries, particularly in China, Japan, and Korea, where it was listed among the premier anti-alcohol herbal medicines in China's first pharmacopoeia, the Tang Materia Medica (659 AD). [1]

Modern research has caught up with that traditional use. Over the past two decades, scientists have begun examining DHM more closely, looking at how this plant compound interacts with the body's alcohol metabolism pathways - and the findings have generated real interest in the supplement world.

DHM belongs to a class of plant compounds called flavonoids - the same broad family that includes quercetin, resveratrol, and catechins found in green tea. These compounds are known for their antioxidant activity and their ability to interact with various biological systems, which is part of why DHM has attracted significant scientific attention beyond traditional herbal medicine.

How Does DHM Work in the Body?

To understand what DHM does, it helps to understand what happens when the body processes alcohol.

When you drink, your liver gets to work breaking alcohol down through a two-step enzymatic process. First, an enzyme called alcohol dehydrogenase (ADH) converts alcohol (ethanol) into acetaldehyde - a reactive compound that is more toxic than alcohol itself. In the second step, another enzyme called aldehyde dehydrogenase (ALDH) converts acetaldehyde into acetate, a much more benign compound the body can process and eliminate normally.

The catch: if acetaldehyde accumulates faster than ALDH can clear it - especially with larger amounts of alcohol, or when the body's enzyme activity is lower - the buildup lingers.

Research has investigated whether DHM plays a role in supporting this metabolic process. A 2020 study published in Alcoholism: Clinical and Experimental Research found that DHM administration resulted in significant elevation of both ADH and ALDH enzymes in the liver of mice fed ethanol - an enhanced the efficiency of these enzymes in converting ethanol into simpler compounds the body can eliminate. [2]

It is worth noting that findings across studies are not uniform. A separate 2020 investigation published in Physiological Research found that DHM did not significantly influence ADH activity in some in vitro models, suggesting that the precise mechanism may vary depending on conditions and that research is still developing. [3] This is typical of the early-to-mid stage of research on many dietary compounds, and reflects why the scientific conversation around DHM continues to be active.

The GABA Connection

DHM also appears to interact with GABA receptors in the brain - a separate pathway from alcohol metabolism. GABA (gamma-aminobutyric acid) is the brain's primary inhibitory neurotransmitter, and alcohol is known to enhance GABA activity, which is partly responsible for its calming and sedative effects. When alcohol clears, the brain's GABA-glutamate balance can shift, contributing to the unsettled feeling many people experience the morning after.

A landmark 2012 study published in The Journal of Neuroscience by Shen et al. examined DHM's interaction with GABA-A receptors and found it counteracted acute ethanol intoxication and withdrawal-related effects in animal models, partly by modulating the GABA receptor response to alcohol. [1] This study is among the most cited in DHM research and laid the groundwork for much of the scientific interest that followed.

The Absorption Problem - and Why It Matters

Here's where many DHM supplements fall short.

DHM is a hydrophilic compound - it dissolves in water but does not cross cell membranes efficiently on its own. That means standard DHM capsules or tablets, while they may contain meaningful amounts of the compound on paper, often deliver far less to your cells than the label suggests.

Bioavailability - the proportion of an ingested substance that actually reaches your bloodstream and tissues - varies enormously depending on how a compound is formulated. Research on DHM pharmacokinetics has noted that absorption is limited by poor uptake and rapid clearance when taken orally in standard form. [1]

Liposomal delivery is one of the most studied solutions to this challenge. Liposomes are microscopic spheres made of phospholipid bilayers - the same structural material as human cell membranes. Because of this structural similarity, liposomal compounds can pass through cell membranes more readily, improving absorption compared to standard oral delivery.

Research published in PubMed and peer-reviewed journals has demonstrated that liposome encapsulation can improve the bioavailability of a variety of compounds - including both hydrophilic and lipophilic substances - by protecting them from gastrointestinal degradation and facilitating better intestinal uptake. [4, 5] A 2023 randomized trial specifically examining liposomal versus non-liposomal supplement formulations found that liposomal delivery resulted in measurably different pharmacokinetic profiles for the nutrients tested. [6]

For a compound like DHM - where standard absorption is already limited - the difference in formulation can meaningfully affect how well the ingredient performs in practice.*

What Does the Research Say Overall?

DHM has been studied primarily in preclinical settings - meaning most of the formal research has been conducted in animal models and cell cultures rather than large-scale human clinical trials. This is the current state of research for most dietary supplement ingredients, and it is worth stating clearly.

What the existing body of research does support:*

  • DHM has demonstrated interactions with GABA-A receptors in the context of alcohol exposure, with the 2012 Shen et al. study representing the most cited work in this area [1]

  • Research has shown DHM supports ethanol-metabolizing enzyme activity in the liver, including ADH and ALDH, though findings across individual studies are not entirely uniform [2, 3]

  • DHM demonstrates antioxidant properties in multiple studies, relevant given the oxidative stress that alcohol metabolism places on the liver [7]

  • The Hovenia dulcis plant from which DHM is derived has a documented history spanning over a thousand years of traditional use in contexts related to alcohol consumption [1]

  • DHM is increasingly studied in combination with other liver-supportive ingredients - including glutathione, milk thistle, B vitamins, and electrolytes - given that alcohol's effects on the body involve multiple systems simultaneously

As with any supplement ingredient, the full picture of human clinical evidence continues to develop. The science is directionally clear and mechanistically grounded - and the research conversation is active enough that new findings continue to emerge.

Why DHM Has Gained Traction in the Wellness World

The growing interest in DHM reflects a broader shift in how wellness-focused consumers think about drinking. For a generation that tracks sleep quality, reads ingredient labels, and takes a considered approach to what goes into their bodies, the idea of proactive, science-informed support after a night out fits naturally alongside other wellness habits.

DHM is not a shortcut or a permission slip. It is an ingredient that supports what the body is already doing - and that framing resonates with people who want balance, not extremes. The same person who watches their nutrition, prioritizes sleep, and maintains an active lifestyle does not suddenly stop caring about their body on a Saturday night. They want tools that fit the life they are actually living.

That is the audience DHM has found: not party culture, but wellness culture. People who celebrate and still show up the next morning.

The Bottom Line

Dihydromyricetin is a well-studied plant flavonoid with over a thousand years of traditional use and a growing body of peer-reviewed research supporting its role in alcohol metabolism pathways, GABA receptor modulation, and antioxidant activity.* The science is directionally strong - but the research is still developing, and delivery method matters significantly. Standard DHM formulations face real absorption limitations that liposomal delivery is specifically designed to address.*

If you are evaluating DHM supplements, look past the milligram count and ask how the ingredient is delivered. Bioavailability is the difference between DHM on a label and DHM that actually reaches your cells.

Found in: Purple Tree Post-Celebration Wellness →

References

  1. Shen Y, et al. Dihydromyricetin as a novel anti-alcohol intoxication medication. Journal of Neuroscience. 2012 Jan 4;32(1):390–401. https://www.jneurosci.org/content/32/1/390

  2. Silva JP, et al. Dihydromyricetin protects the liver via changes in lipid metabolism and enhanced ethanol metabolism. Alcoholism: Clinical and Experimental Research. 2020. https://onlinelibrary.wiley.com/doi/full/10.1111/acer.14326

  3. Skotnicová A, et al. Does dihydromyricetin impact on alcohol metabolism? Physiological Research. 2020;69(Suppl 4):S573–S581. https://pmc.ncbi.nlm.nih.gov/articles/PMC8603706/

  4. Laouini A, et al. Potential of liposomes for enhancement of oral drug absorption. Current Pharmaceutical Biotechnology. 2012. PubMed. https://pubmed.ncbi.nlm.nih.gov/26768542/

  5. Swenson CE, Perkins WR. Liposomal drug delivery. Expert Opinion on Drug Delivery. 2007. PubMed. https://pubmed.ncbi.nlm.nih.gov/17413493/

  6. Gonzalez AM, et al. Pharmacokinetic analyses of liposomal and non-liposomal multivitamin/mineral formulations. Nutrients. 2023. PubMed. https://pubmed.ncbi.nlm.nih.gov/37447400/

  7. Yan T, et al. Dihydromyricetin improves mitochondrial outcomes in the liver of alcohol-fed mice via the AMPK/Sirt-1/PGC-1α signaling axis. PubMed. 2020. https://pubmed.ncbi.nlm.nih.gov/33080338/

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.